Table of Contents

1 Study Coverage

• 1.1 Sartans Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Sartans Market Size Growth Rate by Product
  • 1.4.2 Valsartan
  • 1.4.3 Telmisartan
  • 1.4.4 Losartan
  • 1.4.5 Irbesartan
  • 1.4.6 Azilsartan
  • 1.4.7 Olmesartan
• 1.5 Market by End User
  • 1.5.1 Global Sartans Market Size Growth Rate by End User
  • 1.5.2 Hypertension
  • 1.5.3 Cardiovascular Diseases
  • 1.5.4 Kidney Diseases
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Sartans Market Size
  • 2.1.1 Global Sartans Revenue 2014-2025
  • 2.1.2 Global Sartans Sales 2014-2025
• 2.2 Sartans Growth Rate by Regions
  • 2.2.1 Global Sartans Sales by Regions
  • 2.2.2 Global Sartans Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Sartans Sales by Manufacturers
  • 3.1.1 Sartans Sales by Manufacturers
  • 3.1.2 Sartans Sales Market Share by Manufacturers
  • 3.1.3 Global Sartans Market Concentration Ratio (CR5 and HHI)
• 3.2 Sartans Revenue by Manufacturers
  • 3.2.1 Sartans Revenue by Manufacturers (2014-2019)
  • 3.2.2 Sartans Revenue Share by Manufacturers (2014-2019)
• 3.3 Sartans Price by Manufacturers
• 3.4 Sartans Manufacturing Base Distribution, Product Types
  • 3.4.1 Sartans Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Sartans Product Type
  • 3.4.3 Date of International Manufacturers Enter into Sartans Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Sartans Sales by Product
• 4.2 Global Sartans Revenue by Product
• 4.3 Sartans Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Sartans Breakdown Data by End User

6 North America

• 6.1 North America Sartans by Countries
  • 6.1.1 North America Sartans Sales by Countries
  • 6.1.2 North America Sartans Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Sartans by Product
• 6.3 North America Sartans by End User

7 Europe

• 7.1 Europe Sartans by Countries
  • 7.1.1 Europe Sartans Sales by Countries
  • 7.1.2 Europe Sartans Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Sartans by Product
• 7.3 Europe Sartans by End User

8 Asia Pacific

• 8.1 Asia Pacific Sartans by Countries
  • 8.1.1 Asia Pacific Sartans Sales by Countries
  • 8.1.2 Asia Pacific Sartans Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Sartans by Product
• 8.3 Asia Pacific Sartans by End User

9 Central & South America

• 9.1 Central & South America Sartans by Countries
  • 9.1.1 Central & South America Sartans Sales by Countries
  • 9.1.2 Central & South America Sartans Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Sartans by Product
• 9.3 Central & South America Sartans by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Sartans by Countries
  • 10.1.1 Middle East and Africa Sartans Sales by Countries
  • 10.1.2 Middle East and Africa Sartans Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Sartans by Product
• 10.3 Middle East and Africa Sartans by End User

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Pfizer Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Pfizer Sartans Products Offered
  • 11.1.5 Pfizer Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Novartis Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Novartis Sartans Products Offered
  • 11.2.5 Novartis Recent Development
• 11.3 Merck
  • 11.3.1 Merck Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Merck Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Merck Sartans Products Offered
  • 11.3.5 Merck Recent Development
• 11.4 Astra Zeneca
  • 11.4.1 Astra Zeneca Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Astra Zeneca Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Astra Zeneca Sartans Products Offered
  • 11.4.5 Astra Zeneca Recent Development
• 11.5 Jhonson and Johnson
  • 11.5.1 Jhonson and Johnson Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Jhonson and Johnson Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Jhonson and Johnson Sartans Products Offered
  • 11.5.5 Jhonson and Johnson Recent Development
• 11.6 Eli Lilly
  • 11.6.1 Eli Lilly Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Eli Lilly Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Eli Lilly Sartans Products Offered
  • 11.6.5 Eli Lilly Recent Development
• 11.7 Sanofi
  • 11.7.1 Sanofi Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Sanofi Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Sanofi Sartans Products Offered
  • 11.7.5 Sanofi Recent Development
• 11.8 Bristol-Myers Squibb
  • 11.8.1 Bristol-Myers Squibb Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Bristol-Myers Squibb Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Bristol-Myers Squibb Sartans Products Offered
  • 11.8.5 Bristol-Myers Squibb Recent Development
• 11.9 Bayer
  • 11.9.1 Bayer Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Bayer Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Bayer Sartans Products Offered
  • 11.9.5 Bayer Recent Development
• 11.10 GSK
  • 11.10.1 GSK Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 GSK Sartans Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 GSK Sartans Products Offered
  • 11.10.5 GSK Recent Development
• 11.11 Teva Pharmaceutical

12 Future Forecast

• 12.1 Sartans Market Forecast by Regions
  • 12.1.1 Global Sartans Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Sartans Revenue Forecast by Regions 2019-2025
• 12.2 Sartans Market Forecast by Product
  • 12.2.1 Global Sartans Sales Forecast by Product 2019-2025
  • 12.2.2 Global Sartans Revenue Forecast by Product 2019-2025
• 12.3 Sartans Market Forecast by End User
• 12.4 North America Sartans Forecast
• 12.5 Europe Sartans Forecast
• 12.6 Asia Pacific Sartans Forecast
• 12.7 Central & South America Sartans Forecast
• 12.8 Middle East and Africa Sartans Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Sartans Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Sartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
The global Sartans market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sartans market based on company, product type, end user and key regions.

This report studies the global market size of Sartans in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sartans in these regions.
This research report categorizes the global Sartans market by top players/brands, region, type and end user. This report also studies the global Sartans market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Market size by Product
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Market size by End User
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Sartans market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sartans market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sartans companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sartans submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Sartans are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sartans market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.